The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An overview of N-heterocyclic carbenes
Hopkinson, M. N., Richter, C., Schedler, M., & Glorius, F. (2014) · Nature · doi:10.1038/nature13384 · Cited by 4,264
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Ag(I) N-Heterocyclic Carbene Complexes: Synthesis, Structure, and Application
Garrison, J. C., & Youngs, W. J. (2005) · Chemical Reviews · doi:10.1021/cr050004s · Cited by 1,091
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Self-citationExploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Non Platinum Metal Complexes as Anti‐cancer Drugs
Ott, I., & Gust, R. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600151 · Cited by 609
Self-citationHickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Bindoli, A., Rigobello, M. P., Scutari, G., Gabbiani, C., Casini, A., & Messori, L. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.026 · Cited by 595
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
Ferrocifen type anti cancer drugs
Jaouen, G., Vessières, A., & Top, S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00486a · Cited by 581
Organoiridium Complexes: Anticancer Agents and Catalysts
Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 573
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Metal-based anticancer chemotherapeutic agents
Muhammad, N., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 515
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
Kapdi, A. R., & Fairlamb, I. J. S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00063c · Cited by 379
Mercury Toxicity and Neurodegenerative Effects
Carocci, A., Rovito, N., Sinicropi, M. S., & Genchi, G. (2014) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-3-319-03777-6_1 · Cited by 315
Bioactive iridium and rhodium complexes as therapeutic agents
Leung, C.-H., Zhong, H.-J., Chan, D. S.-H., & Ma, D.-L. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.01.034 · Cited by 303
Ruthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
Functionalization of Platinum Complexes for Biomedical Applications
Wang, X., Wang, X., & Guo, Z. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00203 · Cited by 268
Li, Y., Tan, C.-P., Zhang, W., He, L., Ji, L.-N., & Mao, Z.-W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.070 · Cited by 267
Group 9 Organometallic Compounds for Therapeutic and Bioanalytical Applications
Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2014) · Accounts of Chemical Research · doi:10.1021/ar500310z · Cited by 246
Bertrand, B., Stefan, L., Pirrotta, M., Monchaud, D., Bodio, E., Richard, P., Le Gendre, P., Warmerdam, E., de Jager, M. H., Groothuis, G. M. M., et al. (2014) · Inorganic Chemistry · doi:10.1021/ic403011h · Cited by 245
McKeage, M. J., Maharaj, L., & Berners-Price, S. J. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00048-6 · Cited by 243
Lentz, F., Drescher, A., Lindauer, A., Henke, M., Hilger, R. A., Hartinger, C. G., Scheulen, M. E., Dittrich, C., Keppler, B. K., & Jaehde, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328322fbc5 · Cited by 239
Farrell, N. P. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00201j · Cited by 229
Zou, T., Lum, C. T., Chui, S. S., & Che, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209787 · Cited by 222
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Bergamo, A., & Sava, G. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00134j · Cited by 219
Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
Spreckelmeyer, S., Orvig, C., & Casini, A. (2014) · Molecules · doi:10.3390/molecules191015584 · Cited by 185
Development of anticancer agents: wizardry with osmium
Hanif, M., Babak, M. V., & Hartinger, C. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.016 · Cited by 172
N -Heterocyclic Carbene Metal Complexes as Bio-Organometallic Antimicrobial and Anticancer Drugs
Patil, S. A., Patil, S. A., Patil, R., Keri, R. S., Budagumpi, S., Balakrishna, G. R., & Tacke, M. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.61 · Cited by 169
Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
Wang, X., & Guo, Z. (2008) · Dalton Trans. · doi:10.1039/b715903j · Cited by 160
Hartinger, C. G., Groessl, M., Meier, S. M., Casini, A., & Dyson, P. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35532b · Cited by 157
Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
Mendes, F., Groessl, M., Nazarov, A. A., Tsybin, Y. O., Sava, G., Santos, I., Dyson, P. J., & Casini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000135 · Cited by 151
Zou, T., Lum, C. T., Lok, C., To, W., Low, K., & Che, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400142 · Cited by 151
Citta, A., Schuh, E., Mohr, F., Folda, A., Massimino, M. L., Bindoli, A., Casini, A., & Rigobello, M. P. (2013) · Metallomics · doi:10.1039/c3mt20260g · Cited by 139
Zou, T., Lok, C., Fung, Y. M. E., & Che, C. (2013) · Chemical Communications · doi:10.1039/c3cc40953h · Cited by 135
Yang, C., Mehmood, F., Lam, T., Chan, S. L., Wu, Y., Yeung, C. S., Guan, X., Li, K., Chung, C. Y., Zhou, C., et al. (2016) · Chemical Science · doi:10.1039/c5sc04458h · Cited by 133
Barry, N. P. E., & Sadler, P. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15300a · Cited by 129
Budagumpi, S., Haque, R. A., Endud, S., Rehman, G. U., & Salman, A. W. (2013) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201300483 · Cited by 129
Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes
Bhabak, K. P., Bhuyan, B. J., & Mugesh, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01057j · Cited by 127
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds
Tan, C., Lu, Y., Ji, L., & Mao, Z. (2014) · Metallomics · doi:10.1039/c3mt00225j · Cited by 125
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
Cvitkovic, E. (1998) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(98)90061-5 · Cited by 119
Cheng, X., Holenya, P., Can, S., Alborzinia, H., Rubbiani, R., Ott, I., & Wölfl, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-221 · Cited by 119
Bertrand, B., Citta, A., Franken, I. L., Picquet, M., Folda, A., Scalcon, V., Rigobello, M. P., Gendre, P. L., Casini, A., & Bodio, E. (2015) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-015-1283-1 · Cited by 111
New approaches for medicinal applications of bioinorganic chemistry
Cohen, S. M. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.01.012 · Cited by 110
Rubbiani, R., Schuh, E., Meyer, A., Lemke, J., Wimberg, J., Metzler‐Nolte, N., Meyer, F., Mohr, F., & Ott, I. (2013) · MedChemComm · doi:10.1039/c3md00076a · Cited by 108
Sivaram, H., Tan, J., & Huynh, H. V. (2012) · Organometallics · doi:10.1021/om300444c · Cited by 106
Clinical Status of Cisplatin, Carboplatin, and Other Platinum‐Based Antitumor Drugs
O'Dwyer, P. J., Stevenson, J. P., & Johnson, S. W. (1999) · doi:10.1002/9783906390420.ch2 · Cited by 101
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.025 · Cited by 96
Self-citationNaphthalimide gold(i) phosphine complexes as anticancer metallodrugs
Bagowski, C. P., You, Y., Scheffler, H., Vlecken, D. H. W., Schmitz, D. J., & Ott, I. (2009) · Dalton Transactions · doi:10.1039/b912378d · Cited by 93
Muenzner, J. K., Rehm, T., Biersack, B., Casini, A., de Graaf, I. A. M., Worawutputtapong, P., Noor, A., Kempe, R., Brabec, V., Kašpárková, J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00896 · Cited by 90
Oehninger, L., Kuester, L. N., Schmidt, C., Muñoz‐Castro, A., Prokop, A., & Ott, I. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201302819 · Cited by 82
Gandin, V., Pellei, M., Marinelli, M., Marzano, C., Dolmella, A., Giorgetti, M., & Santini, C. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.09.011 · Cited by 80
Haque, R. A., Iqbal, M. A., Asekunowo, P. O., et al. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0461-8 · Cited by 76
Fung, S. K., Zou, T., Cao, B., Chen, T., To, W., Yang, C., Lok, C., & Che, C. (2016) · Nature Communications · doi:10.1038/ncomms10655 · Cited by 76
Synthesis and in vitro Efficacy Studies of Silver Carbene Complexes on Biosafety Level 3 Bacteria
Panzner, M. J., Deeraksa, A., Smith, A. P., Wright, B. D., Hindi, K. M., Kascatan-Nebioglu, A., Torres, A. G., Judy, B. M., Hovis, C. E., Hilliard, J. K., et al. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200801159 · Cited by 73
Asif, M., Iqbal, M. A., Hussein, M. A., Oon, C. E., Haque, R. A., Ahamed, M. B. K., Majid, A. S. A., & Majid, A. M. S. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.11.034 · Cited by 70
The Design of Gold-Based, Mitochondria-Targeted Chemotherapeutics
Berners‐Price, S. J., & Filipovska, A. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08175 · Cited by 68
Caffeine derived platinum(II) N-heterocyclic carbene complexes with multiple anti-cancer activities
Zhang, J.-J., Che, C., & Ott, I. (2014) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2014.10.041 · Cited by 67
Holenya, P., Can, S., Rubbiani, R., Alborzinia, H., Jünger, A., Cheng, X., Ott, I., & Wölfl, S. (2014) · Metallomics · doi:10.1039/c4mt00075g · Cited by 64
Garner, M. E., Niu, W., Chen, X., Ghiviriga, I., Abboud, K. A., Tan, W., & Veige, A. S. (2014) · Dalton Transactions · doi:10.1039/c4dt02850c · Cited by 56
Baron, M., Bellemin‐Laponnaz, S., Tubaro, C., Basato, M., Bogialli, S., & Dolmella, A. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.08.013 · Cited by 53
Oehninger, L., Spreckelmeyer, S., Holenya, P., Meier, S. M., Can, S., Alborzinia, H., Schur, J., Keppler, B. K., Wölfl, S., & Ott, I. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01159 · Cited by 52
Optimization of cisplatin for the treatment of hormone-dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.029 · Cited by 44
Self-citationPellei, M., Gandin, V., Marinelli, M., et al. (2015) · Dalton Transactions · doi:10.1039/c5dt02934a · Cited by 36
Gold‐NHC complexes as potent bioactive compounds
Al‐Majid, A. M., Sammer Yousuf, B., Choudhary, M. I., Nahra, F., & Nolan, S. P. (2016) · ChemistrySelect · doi:10.1002/slct.201600009 · Cited by 36
A potential rhodium cancer therapy: Studies of a cytotoxic organorhodium(I) complex that binds DNA
McConnell, J. R., Rananaware, D., Ramsey, D. M., Buys, K. N., Cole, M. L., & McAlpine, S. R. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.016 · Cited by 31
4‐Alkylated Silver–N‐Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells
Sandtorv, A. H., Leitch, C., Bedringaas, S. L., Gjertsen, B. T., & Bjørsvik, H. (2015) · ChemMedChem · doi:10.1002/cmdc.201500234 · Cited by 30
Gold Organometallics with Biological Properties
Cinellu, M. A., Ott, I., & Casini, A. (2014) · Wiley eBooks · doi:10.1002/9783527673438.ch04 · Cited by 19
Cited by
Doddi, A., Peters, M., & Tamm, M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00791 · Cited by 519
Gan, M.-M., Liu, J.-Q., Zhang, L., Wang, Y.-Y., Hahn, F. E., & Han, Y.-F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00119 · Cited by 346
Cyclic (Alkyl)- and (Aryl)-(amino)carbene Coinage Metal Complexes and Their Applications
Jazzar, R., Soleilhavoup, M., & Bertrand, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00043 · Cited by 320
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Konkankit, C. C., Marker, S. C., Knopf, K. M., & Wilson, J. J. (2018) · Dalton Transactions · doi:10.1039/c8dt01858h · Cited by 284
Metadata
- Authors
- Liu, W., & Gust, R.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 329
- Pages
- 191-213
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2514483667
- Cited by
- 351
- References
- 90
- FWCI
- 19.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.